Novel Therapeutics for Hair Regrowth
Our aim is to help the millions of men and women who suffer from hair loss by providing a nature inspired and effective solution that can regrow hair.
About Us
Developing novel treatments to address androgenic alopecia.
Amplifica is a biopharmaceutical company focused on developing novel treatments to address androgenic alopecia (hair loss). The company has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair.
News and Publications
Read our latest news.
Amplifica Completes $26 Million Series B Financing to Advance Injectable Pipeline for Hair Growth
Oversubscribed round with proceeds to support continued clinical development SAN DIEGO, CA - Amplifica Holdings Group, Inc. (“Amplifica”), a
Amplifica to Present Positive Clinical Outcomes for AMP-303 at the Society for Investigative Dermatology Annual Meeting
Poster Highlights First-in-Human Results for the Treatment of Androgenetic AlopeciaSan Diego, CA, May 7, 2025 – Amplifica Holdings Group Inc.
